Skip to content

-HEEL BELGIUM

Active
Public limited companyfounded 1968active for 58 yearsBooiebos 25, 9031 Gent, BelgiumKBO/BCE: BE 0400.330.282
Summary

-HEEL BELGIUM has been active since 1968 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.4m and a net result of €358,757. Equity is shrinking by about 3.5% per year across the filed financial years. Its solvency ranks better than 46% of 91 sector peers (NACE 21, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE 21209Manufacture of basic pharmaceutical products and pharmaceutical preparations NACE 21201
3rd oldest company in East Flanders, Pharmaceuticals sector1 site
Size
€11.6mturnover 2025
Staff
59.4 FTE
Equity
€1.4m
Profit
€358,757
Financial health
92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Parent
DELTON Health AG
Auditor: Ernst et Young Reviseurs d'EntreprisesAccounts 64 days early3 of 21 deeds read
Why 92raises riskSize: turnover €11.6m, 59.4 FTE, total assets €3.2mlowers riskFounded in 1968Profit of €358,757 (financial year 2025)Legal form: public limited companyShow the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 35% of its sector peers (NACE 21)
Financial strength · tick = 2024
Average
Solvency 70-1
equity 44.7% of total assets
Liquidity 32-5
short-term debt 55.1% · cash 8.2%
Profitability 70-3
return on assets 11.3%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (26 companies, NACE 21, medium-sized)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025highest value 06-2025: 0.1%▼ -0.1 percentage points vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026lowest value 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €130,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.49, compared with 1.45 in 2024, below the usual 1.5; short-term debt: 55.1% and cash: 8.2% of total assets), and 55.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 21): better than 46% on solvency, 24% on liquidity, 54% on profitability and 18% on growth.

The bankruptcy probability was computed on 22-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Founded in 1968
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Profit of €358,757 (financial year 2025)
NBB · annual accounts
raises risk · Size: turnover €11.6m, 59.4 FTE, total assets €3.2m
Companies of this size fail more often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Legal form: public limited company
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-05-2026, 64 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
64 days early
2024
70 days early
2023
69 days early
2022
69 days early
2021
80 days early
2020
71 days early
2019
73 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 71 days before the deadline; the sector median (NACE 21) for financial year 2024 is 9 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 23 May (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
23-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Resignation: Marc DESCHLER (director and managing…Appointment: Ralph SCHMIDT (director and…
  2. Reappointment: EY Bedrijfsrevisoren BV (statutory auditor)Power of attorney · Director…
  3. Annual accounts filedfinancial year 2025 · full…

Key points

  • Positive: 3rd oldest company in East Flanders, Pharmaceuticals sectorin the Checked rankings No. 3 View
  • Caution: Board changedlatest change 20-07-2026 · 1 in office 1 joined · 1 left View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €358,757 8 years View
  • Controlled by DELTON Health AG parent View
  • Active since 1968founded 14-02-1968 58 years View

By topic

Financials

Financial year
2025
Turnover
€11.6m
Profit
€358,757
Solvency
44.7%
Turnover▼ 1.2%
Net result
20182025
Go to Financials

Board & ownership

Board
1 member
Parent
DELTON Health AG
Auditor
Ernst et Young Reviseurs…
  • Ralph SCHMIDTManaging director
Go to Board & ownership

Timeline

Events
52
Since
1978
Next accounts
by 31-07-2027
  1. 22-05-2025Annual accounts filed
  2. 23-05-2024Annual accounts filed
  3. 16-01-2024Amendment of the articles · Miscellaneous
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21209
Founded
14-02-1968
Year ends
31-12
Peppol
Not found in the Peppol directory
Go to Company details

Articles of association

Provisions read
15
Annual meeting
Last Thursday of April
Purpose
“De studie,de navorsing,het ontwerpen,de analyse,het onderzoek,de farmaco-dynamfe,de…” (deed in Dutch)
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.